Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.21% |
| 2 | Technology | 11.19% |
| 3 | Healthcare | 7.18% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Financials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Beam Therapeutics
BEAM
$3.03B
| $3.63M | ﹤0.01% |
+44,471
| New | +$2.19M |
|
|
LFC
2702
DELISTED
China Life Insurance Company Ltd.
LFC
| $3.63M | ﹤0.01% |
328,335
+176,590
| +116% | +$2.02M |
|
|
CTRA
2703
PUT
DELISTED
Coterra Energy
CTRA
| $3.63M | ﹤0.01% |
223,000
-38,500
| -15% | -$676K |
|
2704
Danaos Corp
DAC
$2.74B
| $3.63M | ﹤0.01% |
169,409
+150,677
| +804% | +$1.94M |
|
|
ESPR
2705
DELISTED
Esperion Therapeutics
ESPR
| $3.62M | ﹤0.01% |
139,041
-127,092
| -48% | -$3.81M |
|
2706
Amphastar Pharmaceuticals
AMPH
$936M
| $3.61M | ﹤0.01% |
179,693
+52,228
| +41% | +$1.02M |
|
2707
Spyre Therapeutics
SYRE
$7.97B
| $3.61M | ﹤0.01% |
18,366
+16,186
| +742% | +$3.35M |
|
|
QEP
2708
DELISTED
QEP RESOURCES, INC.
QEP
| $3.61M | ﹤0.01% |
1,511,188
-2,352,988
| -61% | -$3.48M |
|
2709
Celldex Therapeutics
CLDX
$3.07B
| $3.61M | ﹤0.01% |
+205,922
| New | +$3.71M |
|
|
AD
2710
Array Digital Infrastructure
AD
$3.11B
| $3.61M | ﹤0.01% |
117,577
-44,744
| -28% | -$1.36M |
|
2711
Village Farms International
VFF
$356M
| $3.61M | ﹤0.01% |
355,633
+124,187
| +54% | +$936K |
|
2712
Rigel Pharmaceuticals
RIGL
$868M
| $3.6M | ﹤0.01% |
102,848
+39,464
| +62% | +$1.14M |
|
2713
Cohen & Steers Quality Income Realty Fund
RQI
$1.66B
| $3.6M | ﹤0.01% |
289,966
+270,136
| +1,362% | +$3.15M |
|
2714
McGrath RentCorp
MGRC
$2.74B
| $3.59M | ﹤0.01% |
53,535
-5,312
| -9% | -$338K |
|
|
ZYXI
2715
DELISTED
Zynex
ZYXI
| $3.59M | ﹤0.01% |
293,520
+73,214
| +33% | +$953K |
|
|
SIEN
2716
DELISTED
Sientra, Inc.
SIEN
| $3.58M | ﹤0.01% |
92,046
-58,625
| -39% | -$2.63M |
|
|
KNTE
2717
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.57M | ﹤0.01% |
+89,796
| New | +$3.6M |
|
2718
MillerKnoll
MLKN
$1.58B
| $3.57M | ﹤0.01% |
105,546
+80,691
| +325% | +$2.81M |
|
2719
ProPetro Holding
PUMP
$1.35B
| $3.56M | ﹤0.01% |
482,364
-825,414
| -63% | -$4.59M |
|
2720
PUT
Haemonetics
HAE
$4.73B
| $3.56M | ﹤0.01% |
+30,000
| New | +$3.23M |
|
2721
Expeditors International
EXPD
$24.8B
| $3.56M | ﹤0.01% |
37,383
-203,757
| -84% | -$18.6M |
|
2722
Louisiana-Pacific
LPX
$4.98B
| $3.55M | ﹤0.01% |
95,620
-2,230,896
| -96% | -$74.7M |
|
2723
Terreno Realty
TRNO
$7.26B
| $3.55M | ﹤0.01% |
60,743
-126,083
| -67% | -$7.38M |
|
|
PIAI
2724
CALL
DELISTED
Prime Impact Acquisition I
PIAI
| $3.54M | ﹤0.01% |
+350,733
| New | +$3.48M |
|
2725
Perion Network
PERI
$382M
| $3.54M | ﹤0.01% |
+277,945
| New | +$2.46M |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $25B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.